Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. David Miklos, MD
EIR
•David Miklos, MD•April 7, 2017

David Miklos, MD – FDA EIR, Apr 7, 2017

Record Details

An FDA inspection was conducted at the clinical investigator site of Dr. David Miklos, MD, in Stanford, CA, from April 3 to April 7, 2017. This high-priority CDER Clinical Investigator Data Verification Inspection, conducted under Compliance Program 7348.11, focused on assessing Dr. Miklos’s conduct as Principal Investigator for a specific study protocol. The inspection included a comprehensive review of subject files, informed consent forms, data endpoints, protocol adherence, subject safety, and regulatory records.

A key discussion item identified was that six subjects signed outdated Informed Consent Form (ICF) versions (3 and 5) after initially signing version 4. Dr. Miklos clarified this was based on sponsor instruction within the protocol. His staff committed to addressing this practice with the sponsor, IRB, and management to ensure future compliance. Other minor protocol deviations, such as an incorrect drug dosage for one subject, missed respiratory rate observations, and visits outside targeted windows, were noted in subject files but did not warrant formal observations. Data verification against source documentation was largely confirmed as valid, and an adverse event, initially not listed in the report to FDA, was confirmed to have been reported to the sponsor.

Overall, study records were found to be organized, legible, and complete. Drug control, monitoring activities, and Institutional Review Board documentation were adequate. No FDA Form 483, Inspectional Observations, was issued as a result of this inspection, indicating that while discussions on consenting practices occurred, no formal regulatory actions were required at the inspection's conclusion.

Company
David Miklos, MD
Inspection date
April 7, 2017
Product type
drugs
Office
San Francisco District Office
Person
  • Dustin Tran (Investigator )
View Company Profile

ID · f9922855-d491-462c-834e-d8bab6725c68

Other documents for David Miklos, MD
  • EIR - 2017-07-27July 27, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore David Miklos, MD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.